Illustration of a gray sphere in the lower left, with multicolored twirled objects floating an and around it.

A tetra-agonist peptide (foreground helix) does the work of four separate hormones by binding to four different receptors (shown on the cell in red/blue, violet, blue, and green). “What drives us is the idea that we can design a single drug to treat obesity and simultaneously mitigate the risk of developing a long list of health problems plaguing society,” says Krishna Kumar. Image: Hassan @ScienceBrush

Tufts Chemists Design a Next Generation of Weight Loss Drugs

Combining elements of four hormones into a single drug, researchers hope to address not only obesity, but associated conditions like type 2 diabetes, cancer, and cardiovascular disease

Research at Tufts

The university’s faculty and students are driving thinking and research forward to solve our most pressing challenges—in our communities and around the world.

Ask the Expert

Back to Top